Sarah Boyce's Net Worth
Sarah Boyce's net worth is estimated to be at least $14,540,946.37 as of 11/08/2024. CoreStreet's estimation of Sarah Boyce's net worth is based on their sale of stock and current holding of stock.
Sarah Boyce is CEO at Avidity Biosciences Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 32,880 units of RNA stock on 09/23/2024. Their biggest sale was on 06/13/2024 when they sold 164,233 units of Avidity Biosciences Inc stock for $6,582,458.64. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $14,540,946.37
Most recent insider trade:
- Sept. 23, 2024
Sarah Boyce's Insider Trading History
| Avidity Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 23, 2024 | CEO | 32,880 | $44.00 | Sell | $1,446,720.00 |
Aug. 6, 2024 | CEO | 28,000 | $43.35 | Sell | $1,213,800.00 |
July 9, 2024 | CEO | 28,000 | $39.93 | Sell | $1,118,040.00 |
June 13, 2024 | CEO | 164,233 | $40.08 | Sell | $6,582,458.64 |
June 4, 2024 | CEO | 28,000 | $27.42 | Sell | $767,760.00 |
May 7, 2024 | CEO | 28,000 | $25.54 | Sell | $715,120.00 |
March 12, 2024 | CEO | 28,000 | $22.63 | Sell | $633,640.00 |
March 8, 2024 | CEO | 84,000 | $21.39 | Sell | $1,796,760.00 |
Jan. 22, 2024 | CEO | 5,092 | $10.13 | Sell | $51,581.96 |
Aug. 15, 2022 | CEO | 100 | $22.47 | Sell | $2,247.00 |
| Ionis Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 16, 2018 | Insider | 2,196 | $51.76 | Sell | $113,664.96 |
Jan. 17, 2017 | Insider | 1,361 | $46.29 | Sell | $63,000.69 |
Jan. 19, 2016 | insider | 872 | $41.46 | Sell | $36,153.12 |